The researchers examined data from more than 61,000 patients to compare surgical outcomes for patients who took ACE inhibitors with patients who did not. The results showed that patients on long-term blood medication prior to non-cardiac surgery experienced lower 30-day mortality.
Patients who stopped taking ACE inhibitors a few days prior to surgery and then delayed restarting the drugs had similar outcomes to those who took drugs up until the morning of surgery and then resumed the drugs once appropriate.
Study author Jason Toppin, MD, and his colleagues presented their findings at the 2011 annual meeting of the Society of Cardiovascular Anesthesiologists.
Read the Anesthesiology News report on blood pressure medication.
Related Articles on Anesthesia:
UCSD to Use Nitrous Oxide in Place of More Harmful Gases
New York Anesthesiologist Brings Fraud Cases Against Sutter Hospitals, Payors
ASA Introduces White Paper on Anesthesia Information Management Systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
